Effect of lentinan injection in different treatment administration of oxaliplatin combined with capecitabine in gastric cancer and the effect on the peripheral blood of patients with CEA and CA199 levels
10.3969/j.issn.1005-1678.2017.03.021
- VernacularTitle:香菇多糖注射液不同疗程给药对奥沙利铂联合卡培他宾治疗胃癌效果及对患者外周血CEA、CA199水平的影响
- Author:
Yue ZHANG
;
Yu LUO
;
Xinya XU
- Keywords:
lentinan injection;
asha leigh per;
capecitabine;
gastric cancer;
CEA;
CA199
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(3):78-80
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of lentinan injection in different treatment administration of oxaliplatin combined with capecitabine in treatment of gastric cancer and the effect on the peripheral blood of patients with CEA and CA199 levels.Methods 90 cases in our hospital from September 2009 to September 2012 were selected as research subjects, according to patients with lentinan injection treatment, the patients were divided into A, B and C three groups, the effect and the adverse effects of chemotherapy in three groups of patients, detection of serum CEA and CA-199 levels. Results CR, PR, SD and PD of A groups were 12, 7, 8, 3 cases, RR was 63.3%, obviously higher than that of B, C two groups, the difference was statistically significant (P<0.05), group A patients with leukopenia I,II and III degree were 15, 10, 5 cases of gastrointestinal reaction, I, II, III were 12, 10, 8 cases of abnormal liver function, I, II and III degree were 14, 9, 7 cases.A group, leukopenia, gastrointestinal tract, liver function abnormal lesion was lower than the B group and C group, the difference was statistically significant (P<0.05), CEA, CA199 level before treatment compared to no difference, one course of chemotherapy, after two courses of A, B, C three groups of patients with CEA and CA199 level were before treatment decreased, and the level of group A was significantly lower than that of B, C two B, C group, no significant difference between the two groups. Conclusion Lentinan injection helps to improve the sensitivity of chemotherapy in patients with gastric cancer, reduce adverse drug reactions, reduce the level of tumor markers, improve the prognosis of patients with gastric cancer.
